Robotic Genome Accountability Doctrine

Introduction

The Robotic Genome Accountability Doctrine refers to the legal principle that individuals, institutions, manufacturers, developers, and researchers must remain responsible for the consequences of robotic systems used in genomic analysis and genetic engineering. It seeks to ensure that technological autonomy does not become a means of avoiding legal liability.

Robotic genomic technologies combine artificial intelligence, robotics, genetic sequencing, and genome-editing tools. These technologies can identify genetic disorders, analyse DNA, assist in personalised medicine, and modify genetic material. However, inaccurate genomic predictions, unauthorised genetic modifications, and misuse of genetic information may cause serious harm to individuals and future generations.

The doctrine therefore establishes a framework for determining responsibility, protecting genetic privacy, ensuring scientific reliability, and maintaining human oversight over high-risk genomic technologies.

Meaning and Scope

The doctrine applies to robotic systems involved in:

Automated DNA sequencing and genomic testing.

AI-based genetic diagnosis and disease prediction.

Robotic genome-editing procedures, including CRISPR-assisted systems.

Genetic research involving human embryos or reproductive cells.

Storage and analysis of genomic information.

Automated decisions based on genetic characteristics.

The central principle is that responsibility must be allocated according to the conduct, control, and legal obligations of the parties involved.

Important Case Laws

1. Justice K.S. Puttaswamy (Retd.) v. Union of India (2017), (2017) 10 SCC 1

The Supreme Court recognised privacy as a fundamental right under Article 21 and other constitutional freedoms.

Genetic information is particularly sensitive because it can reveal hereditary diseases, biological relationships, and personal characteristics. The judgment provides a constitutional foundation for protecting genomic information against unlawful collection, disclosure, and misuse.

2. Selvi v. State of Karnataka (2010), (2010) 7 SCC 263

The Supreme Court held that involuntary narcoanalysis, polygraph examinations, and brain electrical activation profile tests violate constitutional protections under Articles 20(3) and 21.

The decision is relevant to the doctrine because it emphasises personal autonomy and protection against compelled investigative techniques. It does not, however, establish a blanket prohibition on DNA testing.

3. Bhabani Prasad Jena v. Orissa State Commission for Women (2010), (2010) 8 SCC 633

The Supreme Court held that DNA testing should not be ordered routinely in disputes involving parentage. Courts must consider the necessity of the test, the interests of the parties, and the consequences of disturbing personal relationships.

This judgment supports the principle that genomic investigations must be justified by a legitimate legal purpose and should not be conducted merely because technology makes them possible.

4. Aparna Ajinkya Firodia v. Ajinkya Arun Firodia (2023), (2023) 8 SCC 633

The Supreme Court considered the use of DNA testing in matrimonial proceedings involving the legitimacy of a child.

The Court emphasised the importance of protecting the child's interests and avoiding unnecessary genetic testing. The judgment is relevant to robotic genomic systems because automated DNA analysis must not override privacy, dignity, or the welfare of affected individuals.

5. Gene Campaign v. Union of India (2024), 2024 INSC 545

The Supreme Court examined the regulatory framework governing genetically modified organisms under the Environment (Protection) Act, 1986 and the 1989 Rules.

The decision is significant for biotechnology accountability because it addresses regulatory oversight, biosafety, and the responsibilities of authorities dealing with genetically engineered organisms.

VoxJuris

Statutory Framework in India

India does not have a single comprehensive statute formally establishing a Robotic Genome Accountability Doctrine. Its principles must be developed through existing laws and regulatory frameworks.

Environment (Protection) Act, 1986: Provides the statutory basis for regulating certain genetically engineered organisms.

1989 Biosafety Rules: Regulate specified activities involving hazardous microorganisms and genetically engineered organisms.

Digital Personal Data Protection Act, 2023: Relevant to digital genomic information, subject to applicable scope and commencement provisions.

Consumer Protection Act, 2019: May provide remedies for defective genomic devices or deficient services.

Criminal Procedure (Identification) Act, 2022: Regulates the collection and handling of specified measurements, including certain biological samples, for identification purposes.

India's 2022 genome-edited plant guidelines and biosafety framework provide a specific regulatory structure for certain plant-genome editing activities.

Press Information Bureau+1

Core Principles of the Doctrine

The proposed doctrine should contain the following principles:

Strict accountability: Developers and manufacturers must be responsible for negligent design, inadequate validation, and foreseeable system failures.

Human supervision: High-risk genome-editing procedures should require qualified human oversight.

Informed consent: Individuals must receive understandable information about genomic procedures and their consequences.

Genetic privacy: Genomic information must be protected against unlawful collection, disclosure, and misuse.

Scientific reliability: Automated genomic results should undergo appropriate validation and independent verification.

Traceability: Institutions should maintain records of genomic procedures, algorithmic decisions, and modifications.

Effective remedies: Persons harmed by negligent genomic procedures should have access to appropriate legal remedies.

Conclusion

The Robotic Genome Accountability Doctrine represents an emerging legal framework for allocating responsibility in robotic genomic research, genetic testing, and genome editing. Although Indian law does not formally recognise a standalone doctrine under this name, constitutional privacy jurisprudence, medical negligence principles, consumer protection law, and biotechnology regulations provide its foundation.

The judgments in Puttaswamy, Selvi, Bhabani Prasad Jena, Aparna Ajinkya Firodia, and Gene Campaign establish important principles concerning privacy, autonomy, scientific investigation, and regulatory responsibility.

A comprehensive legal framework should ensure that no researcher, manufacturer, healthcare institution, or developer can escape accountability merely because a genomic decision was made through an automated system. The ultimate objective is to protect human dignity, genetic privacy, public safety, and the rule of law while encouraging responsible scientific innovation.